2021
DOI: 10.1016/j.jff.2021.104495
|View full text |Cite
|
Sign up to set email alerts
|

Symptoms and quality of life in HIV-infected patients with benign prostatic hyperplasia are improved by the consumption of a newly developed whole tomato-based food supplement. A phase II prospective, randomized double-blinded, placebo-controlled study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 62 publications
0
2
0
Order By: Relevance
“…In view of the fact that metabolic syndrome and chronic inflammation, both considered to be risk factors for BHP, are frequently observed in HIV-infected patients [ 90 ] (in whom PCa incidence is expected to increase in the near future [ 91 ]), a validation study was performed on HIV+ patients with BPH using the treatment schedule. Additionally, in this trial, the daily WTFS consumption resulted in a significant amelioration in LUTSs, quality of life, free/total PSA ratio, and diastolic blood pressure, with a trend in the decrease in the IL-6 serum level [ 92 ].…”
Section: Tomato and Olive Oil In Prostate Healthmentioning
confidence: 99%
“…In view of the fact that metabolic syndrome and chronic inflammation, both considered to be risk factors for BHP, are frequently observed in HIV-infected patients [ 90 ] (in whom PCa incidence is expected to increase in the near future [ 91 ]), a validation study was performed on HIV+ patients with BPH using the treatment schedule. Additionally, in this trial, the daily WTFS consumption resulted in a significant amelioration in LUTSs, quality of life, free/total PSA ratio, and diastolic blood pressure, with a trend in the decrease in the IL-6 serum level [ 92 ].…”
Section: Tomato and Olive Oil In Prostate Healthmentioning
confidence: 99%
“…These effects are associated with significant reductions in the levels of some proinflammatory and proangiogenic cytokines such as VEGF and IL-6 (Pannellini et al, 2010). Furthermore, clinical training and validation trials have shown that WTBFS significantly relieves urinary symptoms and improves the quality of life of patients suffering from benign prostatic enlargement (Cormio et al, 2021; Quiros-Roldan et al, 2021).…”
Section: Introductionmentioning
confidence: 99%